Pediatric anesthesia & critical care

Comparison of postoperative oxygenation in children receiving sugammadex versus neostigmine for reversal of neuromuscular blockade: a retrospective cohort study

Can J AnaesthPublished Retrospective cohort study

Main finding · Mean SpO2/FIO2 ratio, first postoperative hourResult — go to the resultDifference in means −6.2 95% CI −12.8 to 0.41

Authors' conclusion

In this retrospective cohort study, postoperative oxygenation was similar in children after reversal of neuromuscular blockade with sugammadex versus neostigmine.

Study context

Population
Children aged 2–17 yr undergoing noncardiac surgery with GA, Cleveland Clinic Main Campus, January 2017–April 2023
Participants
3,523 cases
Exposure
Sugammadex vs neostigmine for reversal of NMB
  • Sugammadexn = 430
  • Neostigminen = 3,081reference
Outcome
Postoperative oxygenation: mean SpO2/FIO2 ratio during the initial hour in the PACU
Follow-up
First postoperative hour
Methodological detailsinverse probability of treatment weighting, single-centre
  • Inverse probability of treatment weighting
  • Single-centre

Main finding

Mean SpO2/FIO2 ratio, first postoperative hour

Difference in means

−6.2

95% CI −12.8 to 0.41

P = 0.07

By group

Sugammadex

403

median · IQR 356–464

Neostigmine

408

median · IQR 357–462

Sugammadex vs Neostigmine
difference in means −6.2 (95% CI −12.8 to 0.41); P = 0.07

As reported in the abstract

Observational data: associations, not effects.

Secondary outcomes

Composite postoperative pulmonary complications during hospital stay (inpatients)

P = 0.19

Composite postoperative pulmonary complications during hospital stay (inpatients) — Overall PPCs among inpatients
22/1,916 (1.1%)

Original publication

Comparison of postoperative oxygenation in children receiving sugammadex versus neostigmine for reversal of neuromuscular blockade: a retrospective cohort study. Can J Anaesth. Published 30 January 2025. doi:10.1007/s12630-024-02904-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.